Why it was recalled
Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
Product description
Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19
Lot numbers, UPCs & expiration codes
Lot KB60707, 10/31/2018
Where it was sold
The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this recall.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0651-2017
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Apr 4, 2017
- FDA report date
- Apr 19, 2017
- Quantity
- 100 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- West-Ward Columbus, Inc.
Original FDA data
Every field from FDA enforcement report D-0651-2017, exactly as published.
Show all FDA fields
- City
- Columbus
- State
- OH
- Status
- Terminated
- Country
- United States
- Event ID
- 76822
- Address
- 1809 Wilson Rd
- Code information
- Lot KB60707, 10/31/2018
- Postal code
- 43228-9579
- Report date
- Apr 19, 2017
- Product type
- Drugs
- Recall number
- D-0651-2017
- Classification
- Class III
- Recalling firm
- West-Ward Columbus, Inc.
- Product quantity
- 100 bottles
- Termination date
- Sep 4, 2018
- Reason for recall
- Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19
- Distribution pattern
- The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this recall.
- Recall initiation date
- Apr 4, 2017
- Initial firm notification
- Letter
- Center classification date
- Apr 7, 2017